The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
    1. About this group
    2. Reviews
      1. Active chest compression-decompression for cardiopulmonary resuscitationReview
      2. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarctionReview
      3. Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adultsReview
      4. Aminophylline for bradyasystolic cardiac arrest in adultsReview
      5. Amiodarone versus other pharmacological interventions for prevention of sudden cardiac deathReview
      6. Angiotensin receptor blockers for heart failureReview
      7. Anti-inflammatory treatment for carditis in acute rheumatic feverReview
      8. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationReview
      9. Antibiotics for brain abscesses in people with cyanotic congenital heart diseaseReview
      10. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutterReviewWithdrawn
      11. Anticoagulation versus placebo for heart failure in sinus rhythmReview
      12. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythmReviewWithdrawn
      13. Antiplatelet and anticoagulation for patients with prosthetic heart valvesReview
      14. Artichoke leaf extract for treating hypercholesterolaemiaReviewWithdrawn
      15. Bed rest for acute uncomplicated myocardial infarctionReview
      16. Beta-blockers for congestive heart failure in childrenReview
      17. Biphasic versus monophasic waveforms for transthoracic defibrillation in out-of-hospital cardiac arrestReview
      18. Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviewsReviewOverview
      19. Catheter ablation for paroxysmal and persistent atrial fibrillationReview
      20. Chinese herbal medicine suxiao jiuxin wan for angina pectorisReview
      21. Chuanxiong preparations for preventing strokeReviewWithdrawn
      22. Clinical service organisation for heart failureReview
      23. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular diseaseReview
      24. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular diseaseReview
      25. Coenzyme Q10 for heart failureReview
      26. Colchicine for pericarditisReview
      27. Colchicine for prevention of cardiovascular eventsReview
      28. A comparison of different antibiotic regimens for the treatment of infective endocarditisReview
      29. Continuous infusion versus bolus injection of loop diuretics in congestive heart failureReview
      30. Corticosteroids for viral myocarditisReview
      31. Danshen (Chinese medicinal herb) preparations for acute myocardial infarctionReview
      32. Dietary advice for reducing cardiovascular riskReview
      33. Dietary fibre for the primary prevention of cardiovascular diseaseReview
      34. Digitalis for treatment of heart failure in patients in sinus rhythmReview
      35. Diuretics for heart failureReviewWithdrawn
      36. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromesReviewWithdrawn
      37. Drugs and pacemakers for vasovagal, carotid sinus and situational syncopeReview
      38. Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular blockReview
      39. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillationReview
      40. Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardiaReview
      41. Effects of total fat intake on body weightReview
      42. Electrical cardioversion for atrial fibrillation and flutterReview
      43. Enhanced external counterpulsation for chronic angina pectorisReview
      44. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patientsReview
      45. Exercise-based cardiac rehabilitation for adults after heart valve surgeryReview
      46. Exercise-based cardiac rehabilitation for coronary heart diseaseReview
      47. Exercise-based rehabilitation for heart failureReview
      48. Exercise for people with high cardiovascular riskReview
      49. Face-to-face interventions for promoting physical activityReview
      50. Face-to-face versus remote and web 2.0 interventions for promoting physical activityReview
      51. Factor Xa inhibitors for acute coronary syndromesReview
      52. Fibrates for secondary prevention of cardiovascular disease and strokeReview
      53. Fixed-dose combination therapy for the prevention of cardiovascular diseaseReview
      54. Fresh frozen plasma for cardiovascular surgeryReview
      55. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factorsReview
      56. Granulocyte colony stimulating factor therapy for acute myocardial infarctionReview
      57. Green and black tea for the primary prevention of cardiovascular diseaseReview
      58. Hawthorn extract for treating chronic heart failureReview
      59. Heparin versus placebo for non-ST elevation acute coronary syndromesReview
      60. Herbal medicines for viral myocarditisReviewWithdrawn
      61. Home-based versus centre-based cardiac rehabilitationReview
      62. Homocysteine-lowering interventions for preventing cardiovascular eventsReview
      63. Hormone therapy for preventing cardiovascular disease in post-menopausal womenReview
      64. Hyperbaric oxygen therapy for acute coronary syndromeReview
      65. Hypothermia to reduce neurological damage following coronary artery bypass surgeryReview
      66. Immunosuppressive T-cell antibody induction for heart transplant recipientsReview
      67. Implantable defibrillators versus medical therapy for cardiac channelopathiesReview
      68. Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncopeReview
      69. Incentive spirometry for preventing pulmonary complications after coronary artery bypass graftReview
      70. Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseasesReview
      71. Influenza vaccines for preventing cardiovascular diseaseReview
      72. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeReview
      73. Internet-based interventions for the secondary prevention of coronary heart diseaseReview
      74. Interventions for increasing fruit and vegetable consumption in children aged 5 years and underReview
      75. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgeryReview
      76. Interventions for promoting physical activityReview
      77. Interventions for treating obesity in childrenReview
      78. Interventions to improve adherence to lipid lowering medicationReview
      79. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shockReview
      80. Intravenous immunoglobulin for presumed viral myocarditis in children and adultsReview
      81. Intravenous magnesium for acute myocardial infarctionReview
      82. Leukodepletion for patients undergoing heart valve surgeryReview
      83. Lipid-lowering efficacy of atorvastatinReview
      84. Lipid-lowering efficacy of rosuvastatinReview
      85. Low glycaemic index diets for coronary heart diseaseReview
      86. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromesReview
      87. Mechanical versus manual chest compressions for cardiac arrestReview
      88. Mediastinal chest drain clearance for cardiac surgeryReview
      89. 'Mediterranean' dietary pattern for the primary prevention of cardiovascular diseaseReview
      90. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countriesReview
      91. Multiple risk factor interventions for primary prevention of coronary heart diseaseReview
      92. Music for stress and anxiety reduction in coronary heart disease patientsReview
      93. Nitrates for acute heart failure syndromesReview
      94. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedemaReview
      95. Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fractionReview
      96. Nut consumption for the primary prevention of cardiovascular diseaseReview
      97. Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart diseaseReview
      98. Omega 3 fatty acids for prevention and treatment of cardiovascular diseaseReview
      99. Omega 6 fatty acids for the primary prevention of cardiovascular diseaseReview
      100. Optimal loading dose of warfarin for the initiation of oral anticoagulationReview
      101. Oxygen therapy for acute myocardial infarctionReview
      102. Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathyReview
      103. Patient education in the management of coronary heart diseaseReview
      104. Penicillin for secondary prevention of rheumatic feverReview
      105. Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromesReview
      106. Percutaneous transluminal rotational atherectomy for coronary artery diseaseReview
      107. Pharmacological cardioversion for atrial fibrillation and flutterReview
      108. Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathyReviewNew Search
      109. Phosphodiesterase III inhibitors for heart failureReview
      110. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromesReview
      111. Pre-hospital versus in-hospital thrombolysis for ST-elevation myocardial infarctionReview
      112. Preoperative intra aortic balloon pumps in patients undergoing coronary artery bypass graftingReview
      113. Preoperative physical therapy for elective cardiac surgery patientsReview
      114. Preoperative statin therapy for patients undergoing cardiac surgeryReviewWithdrawn
      115. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarctionReviewWithdrawn
      116. Primary stenting versus primary balloon angioplasty for treating acute myocardial infarctionReview
      117. Promoting patient uptake and adherence in cardiac rehabilitationReview
      118. Prophylactic corticosteroids for cardiopulmonary bypass in adultsReview
      119. Prophylactic lidocaine for myocardial infarctionReview
      120. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart diseaseReview
      121. Prophylactic steroids for pediatric open heart surgeryReviewWithdrawn
      122. Psychological and pharmacological interventions for depression in patients with coronary artery diseaseReview
      123. Psychological interventions for coronary heart diseaseReview
      124. Psychological interventions for depression in adolescent and adult congenital heart diseaseReview
      125. Psychological interventions for depression in heart failureReview
      126. Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomyReview
      127. Psychosocial interventions for smoking cessation in patients with coronary heart diseaseReview
      128. Puerarin injection for unstable angina pectorisReviewWithdrawn
      129. Qigong for the primary prevention of cardiovascular diseaseReview
      130. Red cell transfusion management for patients undergoing cardiac surgery for congenital heart diseaseReview
      131. Reduced dietary salt for the prevention of cardiovascular diseaseReview
      132. Reduced or modified dietary fat for preventing cardiovascular diseaseReview
      133. Reduction in saturated fat intake for cardiovascular diseaseReview
      134. Remote and web 2.0 interventions for promoting physical activityReview
      135. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent eraReview
      136. Selenium supplementation for the primary prevention of cardiovascular diseaseReview
      137. Self-monitoring and self-management of oral anticoagulationReviewNew Search
      138. Service organisation for the secondary prevention of ischaemic heart disease in primary careReview
      139. Sexual counselling for sexual problems in patients with cardiovascular diseaseReview
      140. Shengmai (a traditional Chinese herbal medicine) for heart failureReviewWithdrawn
      141. Smoking cessation for the secondary prevention of coronary heart diseaseReview
      142. Statins for acute coronary syndromeReview
      143. Statins for the primary prevention of cardiovascular diseaseReview
      144. Stem cell therapy for chronic ischaemic heart disease and congestive heart failureReview
      145. Stem cell treatment for acute myocardial infarctionReview
      146. Structured telephone support or non-invasive telemonitoring for patients with heart failureReview
      147. Systematic screening for the detection of atrial fibrillationReview
      148. Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular diseaseReview
      149. Tai chi for primary prevention of cardiovascular diseaseReview
      150. Ticlopidine versus oral anticoagulation for coronary stentingReview
      151. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary interventionReview
      152. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectorisReview
      153. Traditional Chinese herbal products for stable anginaReview
      154. Transcendental meditation for the primary prevention of cardiovascular diseaseReview
      155. Transmyocardial laser revascularization versus medical therapy for refractory anginaReview
      156. Trimetazidine for stable anginaReview
      157. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infectionReview
      158. Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)Review
      159. Vitamin K for improved anticoagulation control in patients receiving warfarinReview
      160. Vitamin K for the primary prevention of cardiovascular diseaseReview
      161. Wholegrain cereals for coronary heart diseaseReview
      162. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart diseaseReview
      163. Yoga for secondary prevention of coronary heart diseaseReview
      164. Yoga for the primary prevention of cardiovascular diseaseReview
    3. Protocols
      1. Acupuncture for angina pectorisProtocolWithdrawn
      2. Adrenaline and vasopressin for cardiac arrestProtocol
      3. Angiotensin-converting enzyme inhibitors for congestive heart failure in childrenProtocolWithdrawn
      4. Antibiotics for secondary prevention of coronary heart diseaseProtocol
      5. Aspirin dosage for the prevention of graft occlusion in people undergoing coronary surgeryProtocol
      6. Aspirin for primary prevention of coronary heart diseaseProtocol
      7. B-type natriuretic peptide-guided treatment for heart failureProtocol
      8. Beta-blockers for heart failureProtocolWithdrawn
      9. Beta-blockers for myocardial infarctionProtocolWithdrawn
      10. Beta-blockers for preventing aortic dissection in Marfan's syndromeProtocol
      11. Beta-blockers for unstable anginaProtocol
      12. Bilateral versus single internal mammary artery bypass grafts for coronary arterial atherosclerosisProtocol
      13. Bypass for primary percutaneous intervention or thrombolysis at the nearest hospital for patients suffering ST-elevation myocardial infarctionProtocolWithdrawn
      14. Cardiac resynchronization therapy for dilated cardiomyopathyProtocolWithdrawn
      15. Cardiovascular safety of phosphodiesterase inhibitors for treating erectile dysfunction in elderly menProtocol
      16. Chest pain observation units for patients with symptoms suggestive of acute cardiac ischaemiaProtocol
      17. Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemiaProtocol
      18. Computer-assisted versus oral-and-written history taking for the management of cardiovascular diseaseProtocolWithdrawn
      19. Computer-assisted versus oral-and-written history taking for the prevention of cardiovascular diseaseProtocolWithdrawn
      20. Concomitant atrial fibrillation surgery for people undergoing cardiac surgeryProtocol
      21. Cryoablation versus radiofrequency catheter ablation for AV nodal re-entrant tachycardiaProtocolWithdrawn
      22. Direct thrombin inhibitors and factor Xa inhibitors for atrial fibrillationProtocol
      23. Early invasive versus conservative strategy for non-infarct related artery lesions in ST elevation myocardial infarction with multi-vessel diseaseProtocol
      24. Educational interventions for adults to prevent readmission and complications following cardiovascular surgeryProtocolWithdrawn
      25. Efficacy and safety of ablation for patients with non-paroxysmal atrial fibrillationProtocol
      26. Endothelial progenitor cell capture stents versus drug-eluting stents for angina or acute coronary syndromeProtocol
      27. Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillatorProtocol
      28. Exercise-based cardiac rehabilitation for adults with atrial fibrillationProtocol
      29. Exercise-based cardiac rehabilitation for people with ventricular assist devicesProtocolNew
      30. Exercise-based cardiac rehabilitation in heart transplant recipientsProtocolNew
      31. Fibrates for primary prevention of cardiovascular disease eventsProtocol
      32. Glucocorticoids for decompensated heart failureProtocolWithdrawn
      33. Glycaemic control for patients with acute coronary syndromeProtocolWithdrawn
      34. Health, not weight loss, focused programmes versus conventional weight loss programmes for cardiovascular risk factorsProtocolWithdrawn
      35. Interventions for the prevention of postoperative atrial fibrillation in adult patients undergoing noncardiac thoracic surgeryProtocol
      36. Interventions to improve evidence-based prescribing in heart failureProtocol
      37. Interventions to increase physical activity for people with congenital heart diseaseProtocol
      38. Ivabradine as adjuvant treatment for chronic heart failureProtocolWithdrawn
      39. Limited versus full sternotomy for aortic valve replacementProtocol
      40. Mammalian target of rapamycin inhibitors for heart transplant patientsProtocol
      41. Mammario-arterial anastomosis versus aorto-arterial anastomosis as proximal anastomotic sites in coronary artery bypass surgery for patients with multivessel diseaseProtocol
      42. mHealth education interventions in heart failureProtocol
      43. Mobile phone text messaging to improve adherence to cardiovascular disease secondary prevention interventionsProtocol
      44. Niacin for primary and secondary prevention of cardiovascular eventsProtocol
      45. Non-acute percutaneous coronary intervention versus medical therapy in patients with ischaemic heart diseaseProtocol
      46. Opioids for treating dyspnoea in patients with chronic heart failureProtocolWithdrawn
      47. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular diseaseProtocol
      48. Primary immunosuppression following heart transplantationProtocolWithdrawn
      49. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart diseaseProtocol
      50. Ranolazine for stable angina pectorisProtocol
      51. Reduced salt intake for heart failureProtocol
      52. Remote ischaemic preconditioning for coronary artery bypass graftingProtocol
      53. Risk scoring for the primary prevention of cardiovascular diseaseProtocol
      54. Statins for aortic valve stenosisProtocol
      55. Supplemental plant sterols and stanols for serum cholesterol and cardiovascular diseaseProtocol
      56. Transcatheter valve implantation versus aortic valve replacement for aortic stenosis in high-risk patientsProtocolWithdrawn
      57. Transcatheter versus optimal medical treatment and surgical aortic valve replacement for aortic valve stenosisProtocolWithdrawn
      58. Unfractioned heparin versus bivalirudin in patients undergoing percutaneous coronary intervention for acute coronary syndromeProtocolNew
      59. The use of antiarrhythmics prior to cardioversion or catheter ablation for atrial fibrillationProtocolWithdrawn
      60. Vasopressors and predominantly vasoconstrictive drugs for acute myocardial infarction complicated by cardiogenic shockProtocol
      61. Vitamin C for treating atrial fibrillationProtocolWithdrawn
      62. Vitamin C supplementation for the primary prevention of cardiovascular diseaseProtocol
      63. Yoga for improving functional capacity, quality of life and cardiovascular outcomes in people with heart failureProtocol
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group

SEARCH